Skip to main content

Table 1 Characteristics of CatIBs/FIBs All constructs were characterized regarding CatIB/FIB formation efficiency, quantified as the relative activity of the insoluble CatIB/FIB-containing pellet fraction compared to the crude cell extract (set to 100%), the initial rate activity (kcat; µmolProduct s−1, per subunit) of the lyophilized CatIB preparation, activity retention compared to the soluble enzyme, the relative protein and lipid content based on the initial weight of the lyophilizate and the yield of CatIBs obtained from 100 g wet E. coli cells

From: Tailoring the properties of (catalytically)-active inclusion bodies

Construct

CatIB/FIB formation efficiency [%]

Activity kcat [s−1]

Residual activity [%]d

Rel. protein content lyophilizate [%]

Yield \(\frac{{g_{lyophilizate} }}{{100 g_{cells} }}\) g

Lipid content [%]

Constructs showing robust CatIB/FIB formation efficiency

 TDoT fusions

  TDoT-L-YFP

53.8 ± 7.4 (6)b

na

na

70.0 ± 5.3 (4)

4.9 ± 0.6 (3)

nd

  TDoT-YFP

65.4 ± 4.9 (3)

na

na

69.2 ± 6.8 (2)

5.5 (1)

nd

  TDoT-mCherry

31.8 ± 8.2 (4)b

na

na

85.7 ± 8.3 (2)

3.2 (1)

nd

  TDoT-L-BsLAa

114.1 ± 3.1 (1)

nd

nd

79 (1)

8.6 (1)

nd

  TDoT-L-AtHNLa

76.4 ± 3.5 (1)

4.3 ± 0.2 (1)

11.1

85 (1)

7.3 (1)

nd

  TDoT-L-EcMenDa

90.3 ± 0.2 (1)

nd

nd

93 (1)

12.2 (1)

nd

  TDoT-L-RADH

87.5 ± 3.2 (4)b

0.054 ± 0.008 (3)b

2.0b

84.6 ± 3.9 (3)b

9.7 ± 1.7 (4)b

14.3 ± 0.3 (1)

  TDoT-L-PfBAL

87.7 ± 6.8 (4)b

0.77 ± 0.12 (4)b,c

1.0b,c

71.9 ± 4.5 (4)b,c

8.8 ± 1.0 (8)b

16.4 ± 1.0 (1)c

  TDoT-EcLDC

nd

6.2*10−7 (1)

nd

nd

nd

nd

  EcLDC-L-TDoT

nd

0.71 (1)e

nd

67.9 ± 5.9 (3)e

12.4 ± 3.0 (3)

12.9 ± 3.2 (1)

 3HAMP fusions

  3HAMP-L-RADH

75.4 ± 3.7 (4)

0.33 ± 0.02 (3)

12.0

50.9 ± 7.6 (3)

3.8 ± 0.5 (3)

30.6 ± 8.3 (1)

  3HAMP-L-PfBAL

75.8 ± 8.0 (5)

13.9 ± 2.9 (3)c

18.1c

33.8 ± 5.2 (3)c

3.3 ± 0.5 (4)

30.1 ± 4.7 (1)c

  3HAMP-L-LbADH

67.0 ± 21.7 (3)

0.60 ± 0.20 (3)

1.0

54.6 ± 8.0 (3)

8.1 ± 1.3 (3)

34.7 ± 1.36 (1)

  3HAMP-L-PpBFD

61.3 ± 35.4 (3)

23.4 ± 6.1 (4)

10.3

35.5 ± 6.7 (4)

6.6 ± 1.4 (3)

27.9 ± 3.7 (1)

  EcLDC-L-3HAMP

nd

0.80 (1)

nd

56.5 ± 6.5 (2)

7.5 ± 6.5 (4)

17.7 ± 0.6 (1)

Constructs showing low CatIB/FIB formation efficiency

 TDoT-L-mCherry

3.5 ± 1.9 (3)

na

na

15.8 ± 0.5 (1)

2.8 (1)

nd

 TDoT-L-LbADH

5.4 ± 5.9 (3)

3.63 ± 0.90 (3)

5.8

43.4 ± 5.5 (3)

2.5 ± 0.4 (3)

25.2 ± 0.73 (1)

 TDoT-L-PpBFD

1.2 ± 0.6 (3)

9.2 ± 4.7 (4)

4.1

26.9 ± 4.1 (4)

1.6 ± 0.7 (3)

19.1 ± 0.8 (1)

 3HAMP-L-YFP

6.3 ± 3.2 (4)

na

na

49.0 ± 5.7 (3)

5.4 ± 1.0 (3)

nd

 3HAMP-L-mCherry

5.5 ± 0.2 (5)

na

na

36.4 ± 4.1 (4)

3.0 ± 0.9 (4)

nd

  1. aData taken from [9]
  2. bData taken from [25]
  3. cData taken from [32]
  4. dResidual activity (kca, µmol product, per subunit) relative to the activity of the corresponding soluble purified enzyme: (RADH: kcat = 2.76 ± 0.04 s−1; PfBAL: kcat = 76.7 ± 2.3 s−1; LbADH: kcat = 62.2 ± 6.7 s−1; PpBFD: kcat = 226 ± 40 s−1)
  5. eData given in or derived from [10]. Numbers in brackets refer to the numbers of the biological replicates that were used to obtain error estimates. na: not applicable; nd: not determined